TelyRx Announces First Quarter 2026 Financial Results
Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced financial results for the first quarter ended March 31, 2026. All dollar amounts are expressed in U.S. dollars. Highlights for the First Quarter of 2026 Revenue increased to $19.4 million, compared to $14.3 million in Q4 2025 and $6.9 million in Q1 2025 Number of Prescriptions...
2026-05-12 5:57 PM EDT
TelyRx to Host First Quarter 2026 Financial Results Conference Call on Wednesday, May 13, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its first quarter 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market...
2026-05-12 10:45 AM EDT
TelyRx Announces Year-End 2025 Financial Results
Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars. Highlights for the Year and Fourth Quarter of 2025 Revenue increased to...
2026-04-21 4:49 PM EDT
TelyRx Holdings Inc. to Commence Trading on the Toronto Stock Exchange Effective April 7, 2026
Clearwater, Florida--(Newsfile Corp. - April 7, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced that its subordinate voting shares will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "TELY" effective Tuesday, April 7, 2026. This milestone follows the completion of its go-public transaction pursuant to the combination with Apolo V...
2026-04-07 7:00 AM EDT
Apolo V Acquisition Corp. Announces Filing of Filing Statement in Connection with Qualifying Transaction
Toronto, Ontario--(Newsfile Corp. - March 24, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V") is pleased to announce that it has filed its filing statement (the "Filing Statement") dated March 24, 2026 on its SEDAR+ profile in connection with the proposed business combination among Apolo V, TelyRx, Inc. ("TelyRx"), TelyRx Finco Inc. ("Finco"), 1001474388 Ontario Inc., and Apolo V MergerCo Inc. (the "Proposed Transaction"). In conjunction with, and on or about March 26, 2026, Finco...
2026-03-24 8:33 PM EDT
Apolo V Acquisition Corp. Announces Shareholder Approvals
Toronto, Ontario--(Newsfile Corp. - March 6, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo" or the "Company"), a "capital pool company" pursuant to the policies of the TSX Venture Exchange (the "TSXV"), is pleased to announce the voting results from its Special Meeting of Shareholders (the "Apolo Meeting") held on Thursday, March 5, 2026 in connection with its previously announced proposed qualifying transaction (the "Qualifying Transaction") with TelyRx, Inc. ("TelyRx"). All...
2026-03-06 9:08 AM EST
Apolo V Acquisition Corp. Amendment to Definitive Agreement with TelyRx, Inc. and Rescheduling of Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V" or the "Company") announces it has amended its business combination agreement with TelyRx, Inc. ("TelyRx") dated January 19, 2026 (the "Business Combination Agreement") effected in connection with its previously announced proposed qualifying transaction (the "Qualifying Transaction") and postponed its special meeting of shareholders (the "Meeting"), which had been scheduled to be held...
2026-02-20 12:10 PM EST
Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.
Toronto, Ontario--(Newsfile Corp. - January 21, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V" or the "Company") and TelyRx, Inc. ("TelyRx"), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce they have entered into a business combination agreement dated January 19, 2026 (the "Business Combination Agreement"), among others, to complete a go-public transaction for TelyRx (the "Proposed Transaction") that will constitute...
2026-01-21 4:42 PM EST
Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo") and TelyRx, Inc. ("TelyRx"), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce that they have entered into a non-binding letter of intent dated December 5, 2025, which outlines the principle terms and conditions pursuant to which Apolo and TelyRx will complete a transaction that will result in a reverse take-over of Apolo by...
2025-12-05 2:25 PM EST
Apolo V Acquisition Corp. Completes Initial Public Offering
Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - Apolo V Acquisition Corp. (the "Corporation"), a capital pool company ("CPC") as defined under Policy 2.4 - Capital Pool Companies (the "CPC Policy") of the TSX Venture Exchange (the "Exchange"), is pleased to announce that it has successfully completed an initial public offering (the "IPO") of 8,000,000 common shares of the Corporation (each, a "Common Share") at a price of $0.10 per Common Share for gross proceeds of $800,000. It is...
2025-10-24 10:18 AM EDT
Apolo V Acquisition Corp. Obtains Receipt for Final Prospectus for Initial Public Offering
Toronto, Ontario--(Newsfile Corp. - September 18, 2025) - Apolo V Acquisition Corp. (the "Corporation"), a capital pool company ("CPC") as defined under Policy 2.4 - Capital Pool Companies (the "CPC Policy") of the TSX Venture Exchange (the "Exchange"), is pleased to announce that, on September 18, 2025, it obtained a receipt for its final prospectus dated September 16, 2025 (the "Prospectus") from the securities regulatory authorities in Ontario, British Columbia and Alberta in connection...
2025-09-18 12:42 PM EDT